ATAGI recommends third vax dose for 500,000 patients
And a small group of patients will need three more doses
Half a million severely immunocompromised patients should be getting a third dose of a COVID-19 vaccine, including those on chemotherapy, high-dose corticosteroids, B-cell-depleting therapies and long-term dialysis, ATAGI has recommended.
It’s the first time ATAGI has advised anything beyond a two-dose course, although potential boosters for doctors and other health staff are still under review, with more advice expected to arrive by the end of the month.
